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Abstract
Carcinosarcoma of the breast, also known as metaplastic carcino-
ma, is rare with very few cases reported in the literature. A 46-year 
old female patient presented with a mass in her left breast. Physi-
cal examination, ultrasonography and mammography findings were 
consistent with malignancy. The mass was totally removed. His-
topathological examination revealed carcinosarcoma of the breast. 
Histologic grade of the tumour was III. Ki67 proliferation index 
was found 40% positive. Tumour cells were positive for p53 (70% 
positive), c-erb-B2 (5% positive), pancytokeratin and EMA in car-
cinomatous areas, and vimentin in sarcomatous areas. There was no 
metastasis in axillary lymph node and distant metastasis. The pa-
tient is receiving chemotherapy and is under follow-up in the 54th 
month. Along with a review of the literature, we present the infor-
mation regarding the clinical and histological findings and treat-
ment of the patient who was operated due to breast carcinosarcoma.
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Introduction
Carcinosarcoma  of  the  breast  is  a  malignant  sarcomatoid 
metaplasia of epithelial carcinoma. This tumor is believed 
to behave differently from the carcinoma or sarcoma of the 
breast. There is controversy about its origin. Presentation of 
the findings about patients diagnosed with breast carcinoma 
will help demonstrate the characteristics of the disease.
Case Report
A 46-year old perymenopausal woman (married, having 2 
children) presented with a mass present in her right breast 
which has grown rapidly in 2 months. Physical examination 
showed a firm mass of 3 cm in greatest dimension with ir-
regular boundaries in the upper inner quadrant of the right 
breast and no enlarged lymph nodes in the axillary region. 
Ultrasonography revealed a solid hypoechoic mass of 2.5 
cm in greatest dimension displaying irregular boundaries. A 
radiopaque lesion with irregular boundaries was monitored 
in mammography. The mass was totally excised under local 
anesthesia. In gross description the mass measured 2.6 x 2.5 
x 2.5 cm and revealed disorganization presenting areas with 
epithelial and mesenchymal characteristics on histopatho-
logical examination. Extensive necrosis was also observed. 
No lymphovascular thrombi was detected. Epithelial areas 
with a ductal nature were determined to be of histologic 
grade III with a total score of 9 (according to the Notting-
ham modification of Bloom-Richardson grading) consisting 
of 3 for tubule formation, 3 for nuclear pleomorphism, and 3 
for mitotic rate. Ki67 proliferation index was 40% positive. 
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Figure 1. Circular tumor areas containing focally necrosis and in-
filtration of adipose tissue were seen (HE x 40).
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Tumor cells were positive for p53 (70% positive), c-erb-B2 
(5% positive),pan-cytokeratin and EMA in carcinomatous 
areas, and vimentin in sarcomatous areas. All tumor cells 
were negative for estrogen, progesterone, desmin and SMA 
(Fig. 1, 2, 3, 4). No metastasis was found in systemic radio-
logical investigations. Right modified radical mastectomy 
was performed. No residual tumor was found in the exci-
sion area in the mastectomy specimen. Histopathological ex-
amination of the 26 lymph nodes dissected from the axillary 
material was consistent with ‘reactive hyperplasia’. Having 
received 6 courses chemotherapy, the case is now in her 54th 
month and under follow-up with no disease.
Discussion
  
Carcinosarcoma  of  the  breast  is  a  malignant  sarcomatoid 
metaplasia of epithelial carcinoma and is rare. It accounts 
for 0.08 - 0.2% of all malignant breast lesions [1-3]. Car-
cinosarcoma is a general term describing biphasic lesions 
simultaneously containing malignant epithelial and malign 
mesenchymal tissue components. It has been reported that 
axillary lymph node of this tumor is less frequently involved 
and it behaves differently from the carcinoma or sarcoma of 
the breast with a worse prognosis than classical breast car-
cinoma [2, 4]. 
The  origin  of  breast  carcinosarcoma  is  controversial. 
Myoepithelial cells are believed to originate from a single 
stem cell like spindle-cells. They have also been reported to 
develop from existing cystosarcoma phyllodes, fibroadeno-
ma and cystic backgrounds [5-8]. 
The epithelial component in a tumor may be composed 
of undifferentiated carcinoma, adenocarcinoma, in situ carci-
noma, infiltrative ductal carcinoma or squamous carcinoma. 
Mesenchymal components may contain different elements 
ranging from undifferentiated mesenchymal areas to fibro-
blastic, chondroblastic or osteoblastic areas [9-12].
Clinical findings often reveal swelling in the breast or 
a palpable mass. Patients usually present with a large mass. 
Rarely, nipple discharge, nipple retraction or skin ulceration 
may also be present [9].
Hormone receptors and c-erb-B2 are usually negative 
[4, 10]. They spread via the blood and lymphatic circula-
tion. The most common distant metastasis areas are lungs 
[13]. Neoplastic cells disposed to local recurrence as they 
are prevail in the perivascular tissue [7]. Prevention of lo-
cal recurrence is of particular importance and radiotherapy is 
significant in preventing recurrence. 
Its diagnosis and treatment involve some difficulties. A 
multidisciplinary approach is required for treatment. Modi-
fied radical mastectomy is preferred in surgical treatment. 
Anthracycline/taxane-based chemotherapy is recommended 
Figure 2. Viable neoplastic cells were seen in between extensive 
necrosis areas (HE x 200).
Figure 3. Vesicular chromatin structure and several mitotic fig-
ures were seen in tumor cells (HE x 400). 
Figure 4. Diffuse and strong nuclear immunohistochemical p53 
positivity was seen in tumor cells.
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for chemotherapy [14]. It is an aggressive type of tumor. 
However, no significant difference was found when it was 
compared to high-grade receptor-negative infiltrative carci-
nomas [4].
Carcinosarcoma of the breast is an aggressive type of 
breast cancer with worse prognosis than classical breast car-
cinomas.  Tumor  size,  differentiation  rate,  high  histologic 
grade, atypia and active pleomorphic spindle cells play a role 
in prognosis [15].
Recently, Hennessy et al. reported on 100 patients with 
biphasic metaplastic sarcomatoid carcinoma and 98 patients 
with carcinosarcoma identified through the SEER database. 
The authors identified 5-year overall survival (OS) at stage 
I, II, II and IV as 0.73, 0.59, 0.44, and 0.00, respectively. 
Our case is recurrence- and metastasis-free in the 54th month 
under follow-up [4].
Carcinosarcoma of the breast is rare and there are a few 
numbers of published cases. In order to gain insight into the 
similar and different characterizing aspects of breast cancer, 
diagnosed cases should be reported with a literature review 
and this rare entity should be kept in mind.
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